Literature DB >> 17376879

Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies.

Claude-Edouard C Michel1, Christopher Sonnex, Christopher A Carne, John A White, Jose Paolo V Magbanua, Elpidio Cesar B Nadala, Helen H Lee.   

Abstract

Urethral and endocervical swabs and self-collected vaginal swabs (SCVSs) and urine specimens are all used as samples for diagnosis of urogenital infection with Chlamydia trachomatis. We have now determined chlamydial organism load in matched specimens from different anatomic sites and examined its relation to clinical signs and symptoms in men and women. Organism load was measured with assays based on the ligase chain reaction or real-time PCR analysis. The mean organism loads in 58 infected men were 1,200 and 821 elementary bodies (EBs) per 100 microl of sample for first-void urine (FVU) and urethral swabs, respectively (P>0.05). Organism load in FVU samples or urethral swabs was positively associated with symptoms (P<0.01) and clinical signs (P<0.01) in men. The mean organism loads in 73 infected women were 2,231, 773, 162, and 47 EBs/100 microl for endocervical swabs, SCVSs, urethral swabs, and FVU samples, respectively (P<0.001 for each comparison). Only the presence of multiple symptoms or clinical signs was associated with organism load in women. These results show that FVU is a suitable noninvasive sample type for men, given the fact that its chlamydial load did not differ significantly from that of urethral swabs. Given their higher organism load compared with FVU, SCVSs are the preferred noninvasive sample type for women.

Entities:  

Mesh:

Year:  2007        PMID: 17376879      PMCID: PMC1865904          DOI: 10.1128/JCM.00100-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Rapid and simple point of care diagnostics for STIs.

Authors:  D Mabey; R W Peeling; M D Perkins
Journal:  Sex Transm Infect       Date:  2001-12       Impact factor: 3.519

2.  Volume effect on sensitivity of nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens from females.

Authors:  Jeanne Moncada; Joan M Chow; Julius Schachter
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

3.  Population-based strategies for outreach screening of urogenital Chlamydia trachomatis infections: a randomized, controlled trial.

Authors:  Berit Andersen; Frede Olesen; Jens K Møller; Lars Østergaard
Journal:  J Infect Dis       Date:  2002-01-03       Impact factor: 5.226

4.  Vulvovaginal-swab or first-catch urine specimen to detect Chlamydia trachomatis in women in a community setting?

Authors:  Sue Skidmore; Paddy Horner; Alan Herring; Joanne Sell; Ian Paul; Jane Thomas; E Owen Caul; Matthias Egger; Anne McCarthy; Emma Sanford; Chris Salisbury; John Macleod; Jonathan A C Sterne; Nicola Low
Journal:  J Clin Microbiol       Date:  2006-10-25       Impact factor: 5.948

5.  Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study.

Authors:  L Ostergaard; B Andersen; J K Møller; F Olesen
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

6.  Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens.

Authors:  Charlotte A Gaydos; Mellisa Theodore; Nicholas Dalesio; Billie Jo Wood; Thomas C Quinn
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

Review 7.  Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies.

Authors:  E J Adams; A Charlett; W J Edmunds; G Hughes
Journal:  Sex Transm Infect       Date:  2004-10       Impact factor: 3.519

8.  Sensitivity requirements for the point of care diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in women.

Authors:  P Vickerman; C Watts; M Alary; D Mabey; R W Peeling
Journal:  Sex Transm Infect       Date:  2003-10       Impact factor: 3.519

9.  Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis.

Authors:  Delphine Hu; Edward W Hook; Sue J Goldie
Journal:  Ann Intern Med       Date:  2004-10-05       Impact factor: 25.391

10.  Preference among female Army recruits for use of self-administrated vaginal swabs or urine to screen for Chlamydia trachomatis genital infections.

Authors:  Y-H Hsieh; M R Howell; J C Gaydos; K T McKee; T C Quinn; C A Gaydos
Journal:  Sex Transm Dis       Date:  2003-10       Impact factor: 2.830

View more
  38 in total

1.  [Diagnosis and treatment of Chlamydia trachomatis infections].

Authors:  T Meyer
Journal:  Hautarzt       Date:  2012-01       Impact factor: 0.751

2. 

Authors:  Christina Korownyk; Roni Y Kraut; Michael R Kolber
Journal:  Can Fam Physician       Date:  2018-06       Impact factor: 3.275

3.  Vaginal self-swabs for chlamydia and gonorrhea.

Authors:  Christina Korownyk; Roni Y Kraut; Michael R Kolber
Journal:  Can Fam Physician       Date:  2018-06       Impact factor: 3.275

4.  Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2014-03-14

5.  Comparing urine samples and cervical swabs for Chlamydia testing in a female population by means of Strand Displacement Assay (SDA).

Authors:  Siren Haugland; Turid Thune; Beata Fosse; Tore Wentzel-Larsen; Stig Ove Hjelmevoll; Helge Myrmel
Journal:  BMC Womens Health       Date:  2010-03-25       Impact factor: 2.809

6.  Real-time quantitative PCR to determine chlamydial load in men and women in a community setting.

Authors:  R Wiggins; S Graf; N Low; P J Horner
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

7.  Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection.

Authors:  Gillian S Wills; Patrick J Horner; Rosy Reynolds; Anne M Johnson; David A Muir; David W Brown; Alan Winston; Andrew J Broadbent; David Parker; Myra O McClure
Journal:  Clin Vaccine Immunol       Date:  2009-04-08

8.  Optimal method of collection of first-void urine for diagnosis of Chlamydia trachomatis infection in men.

Authors:  Craig A Wisniewski; John A White; Claude-Edouard C Michel; Lourdes Mahilum-Tapay; Jose Paolo V Magbanua; Elpidio Cesar B Nadala; Penelope J Barber; Beng T Goh; Helen H Lee
Journal:  J Clin Microbiol       Date:  2008-01-30       Impact factor: 5.948

9.  Chlamydia trachomatis variant not detected by plasmid based nucleic acid amplification tests: molecular characterisation and failure of single dose azithromycin.

Authors:  Jose Paolo V Magbanua; Beng Tin Goh; Claude-Edouard Michel; Aura Aguirre-Andreasen; Sarah Alexander; Ines Ushiro-Lumb; Catherine Ison; Helen Lee
Journal:  Sex Transm Infect       Date:  2007-06-13       Impact factor: 3.519

10.  Performance evaluation of a new rapid urine test for chlamydia in men: prospective cohort study.

Authors:  Elpidio-Cesar Nadala; Beng T Goh; Jose-Paolo Magbanua; Penelope Barber; Alison Swain; Sarah Alexander; Vivian Laitila; Claude-Edouard Michel; Lourdes Mahilum-Tapay; Ines Ushiro-Lumb; Catherine Ison; Helen H Lee
Journal:  BMJ       Date:  2009-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.